Intrepid Chris Sparrow is running six marathons in six days through the desert dressed as a Star Wars storm trooper to raise money for the Cystic Fibrosis Trust, and jokingly tells anyone who doubts he’ll go the distance: “I find your lack of faith disturbing.” What made him decide to take on this insane challenge? Read on to find out!
With genetic tracking in the news as researchers seek to understand more about COVID-19, we wanted to share how researchers funded by the Trust are using it to both improve treatments for CF infections and help reduce cross-infection between people living with cystic fibrosis.
With over 2,000 known mutations of the cystic fibrosis (CF) gene, CF affects everyone with the condition differently. At the Cystic Fibrosis Trust we’re committed to finding the most effective ways of treating everyone with CF, including those who won’t benefit from the ‘CFTR modulators’ currently available. Find out what progress has been made so far.
Mycobacterium abscessus is a growing problem for people with CF across the globe. The Cystic Fibrosis Trust is investing in more long-term research to beat the bug!
Antimicrobial resistance (AMR) is a global concern but particularly so for people with cystic fibrosis (CF). Today we published the second ‘Research in focus’ report, on the work we are doing to tackle antimicrobial resistance. The report highlights the impact AMR has on the lives of people with CF and how our innovations into developing better, more effective treatments may help solve AMR for all those with drug-resistant infections.
Today we published the first of a new series of ‘Research in focus’ reports, on CF-related diabetes. The report explains the impact CF-related diabetes has on the lives of people with cystic fibrosis (CF), what we’ve learnt from our funding so far, and how a new Strategic Research Centre grant could pave the way for insulin-injection free treatments in the future.
